Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J H Porter

Showing results (41-50 of 232) with videos related to

Pageof 24
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2011
Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administrationTri-Hung Nguyen, Tracey Hanley, Christopher J H Porter, et al.
The Journal of Pharmacy and Pharmacology|February 9, 2002
Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic productsLeab Sek, Christopher J H Porter, Ann Marie Kaukonen, et al.
Journal of Pharmaceutical Sciences|April 18, 2014
Lipid-based formulations solidified via adsorption onto the mesoporous carrier Neusilin® US2: effect of drug type and formulation composition on in vitro pharmaceutical performanceHywel D Williams, Michiel Van Speybroeck, Patrick Augustijns, et al.
Drug Delivery and Translational Research|March 20, 2015
Nanostructured reverse hexagonal liquid crystals sustain plasma concentrations for a poorly water-soluble drug after oral administrationTri-Hung Nguyen, Tracey Hanley, Christopher J H Porter, et al.
Pharmaceutical Research|April 28, 2011
Fatty acid binding proteins: potential chaperones of cytosolic drug transport in the enterocyte?Natalie L Trevaskis, Gary Nguyen, Martin J Scanlon, et al.
The Journal of Pharmacy and Pharmacology|June 1, 2006
Examination of the impact of a range of Pluronic surfactants on the in-vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquoneLeab Sek, Ben J Boyd, William N Charman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 26, 2004
Influence of physicochemical properties on the patterns of association of a series of aliphatic esters of halofantrine with plasma lipoproteinsMichelle P McIntosh, William N Charman, Michael Campbell, et al.
Molecular Pharmaceutics|March 17, 2021
Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and PermeabilityYusuke Tanaka, Tri-Hung Nguyen, Estelle J A Suys, et al.
Molecular Pharmaceutics|January 19, 2012
Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulationLisa M Kaminskas, Victoria M McLeod, Christopher J H Porter, et al.
Journal of Pharmaceutical Sciences|February 15, 2003
Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugsGreg A Kossena, Ben J Boyd, Christopher J H Porter, et al.
Pageof 24

Showing results (41-50 of 232) with videos related to

Sort By:
Pageof 24
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2011
Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administrationTri-Hung Nguyen, Tracey Hanley, Christopher J H Porter, et al.
The Journal of Pharmacy and Pharmacology|February 9, 2002
Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic productsLeab Sek, Christopher J H Porter, Ann Marie Kaukonen, et al.
Journal of Pharmaceutical Sciences|April 18, 2014
Lipid-based formulations solidified via adsorption onto the mesoporous carrier Neusilin® US2: effect of drug type and formulation composition on in vitro pharmaceutical performanceHywel D Williams, Michiel Van Speybroeck, Patrick Augustijns, et al.
Drug Delivery and Translational Research|March 20, 2015
Nanostructured reverse hexagonal liquid crystals sustain plasma concentrations for a poorly water-soluble drug after oral administrationTri-Hung Nguyen, Tracey Hanley, Christopher J H Porter, et al.
Pharmaceutical Research|April 28, 2011
Fatty acid binding proteins: potential chaperones of cytosolic drug transport in the enterocyte?Natalie L Trevaskis, Gary Nguyen, Martin J Scanlon, et al.
The Journal of Pharmacy and Pharmacology|June 1, 2006
Examination of the impact of a range of Pluronic surfactants on the in-vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquoneLeab Sek, Ben J Boyd, William N Charman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 26, 2004
Influence of physicochemical properties on the patterns of association of a series of aliphatic esters of halofantrine with plasma lipoproteinsMichelle P McIntosh, William N Charman, Michael Campbell, et al.
Molecular Pharmaceutics|March 17, 2021
Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and PermeabilityYusuke Tanaka, Tri-Hung Nguyen, Estelle J A Suys, et al.
Molecular Pharmaceutics|January 19, 2012
Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulationLisa M Kaminskas, Victoria M McLeod, Christopher J H Porter, et al.
Journal of Pharmaceutical Sciences|February 15, 2003
Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugsGreg A Kossena, Ben J Boyd, Christopher J H Porter, et al.
Pageof 24